Transcription of Rates, management, and outcome of rivaroxaban bleeding in ...
{{id}} {{{paragraph}}}
From by guest on December 10, 2015. For personal use only. Regular Article THROMBOSIS AND HEMOSTASIS. Rates, management , and outcome of rivaroxaban bleeding in daily care : results from the Dresden NOAC registry Jan Beyer-Westendorf,1 Kati Forster, 1. Sven Pannach,2 Franziska Ebertz,1 Vera Gelbricht,1 Christoph Thieme,1. 1 1. Franziska Michalski, Christina Kohler, Sebastian Werth,1 Kurtulus Sahin,3 Luise Tittl,1 Ulrike Hansel, 1. and Norbert Weiss1. 1. Center for Vascular Medicine and Department of Medicine III, Division of Angiology, and 2 Department of Medicine I, Division of Gastroenterology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany; and 3 ClinStat GmbH, Institute for Clinical Research and Statistics, Cologne, Germany Worldwide, rivaroxaban is increasingly used for stroke prevention in atrial fibrillation and Key Points treatment of venous thromboembolism, but little is known about rivaroxaban -related In a real-world setting, bleeding complications in daily care .
Dec 10, 2015 · Regular Article THROMBOSIS AND HEMOSTASIS Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Management and Registry, Registry, National Registry Skill Sheets, Jones & Bartlett Learning, Management, COMPREHENSIVE EMERGENCY MANAGEMENT PLAN FOR, The Fundamentals of Asset Management, Fundamentals of Asset Management, COMPREHENSIVE EMERGENCY MANAGEMENT PLAN, COMPREHENSIVE EMERGENCY MANAGEMENT PLAN CEMP, The International Registry of Acute Aortic, Department of Defense, Human resources for health information system